Navigation Links
Hepatitis B Foundation Advocates are ‘Making the Link’ Between Viral Hepatitis and Liver Cancer in Philadelphia
Date:5/31/2016

More than 80 representatives of the Hepatitis B Foundation, Hepatitis C Allies of Philadelphia, Hep B United Philadelphia, and the Prevent Cancer Foundation held an event on National Hepatitis Testing Day outside of Philadelphia City Hall to raise awareness of the silent epidemic in the city of viral hepatitis, the leading cause of liver cancer.

Foundation leaders and the citywide coalition they created, Hep B United Philadelphia, helped organize the press conference to urge city leaders to support increased testing and treatment for hepatitis B and hepatitis C in Philadelphia’s at-risk populations in order to prevent disease and death from liver cancer, which is the second deadliest cancer.

“Hepatitis B and C viruses are serious public health concerns. An estimated 5 million Americans and 65,000 Philadelphians are living with these viruses, which are leading causes of liver cancer and the most common reason for liver transplants,” Philadelphia Councilwoman Cindy Bass said at the press conference. Bass represents the 8th Council District in Northwest Philadelphia. “And most people living with hepatitis B and C are not aware of their infection.”

Philadelphia City Councilman-at-large David Oh presented the group with a City Council Resolution expressing support of increased attention to viral hepatitis infection and its consequences, the most significant of which is liver cancer. While rates of other cancers are declining, the rate of liver cancer is increasing in the United States. A little known fact is that liver cancer’s 5-year survival rate is less than 12 percent. Making the link between chronic viral hepatitis and liver cancer is essential to saving lives.

“While the Hepatitis B Foundation is supporting research into treatment for hepatitis B infection, we also are doing everything we can to call for increased screening, education and access to life-saving care for Philadelphia residents,” said Chari Cohen, DrPH, MPH, Director of Public Health for the Hepatitis B Foundation.

Also in attendance at the event were former Philadelphia City Health Commissioner and Hepatitis B Foundation board member Dr. Walter Tsou; Dr. Hie-Won Hann, Professor of Medicine, Thomas Jefferson University Hospital; Dr. Edith Mitchell, Professor of Medical Oncology at Thomas Jefferson University; Dr. Carolyn Johnson, Philadelphia Acting Deputy Health Commissioner and Director of the Division of Disease Control of the Philadelphia Department of Health; Carolyn Aldigé, President and Founder, Prevent Cancer Foundation; Dr. Philip Siu, Medical Director, Chinatown Medical Services; and Jin Yun Yang, a Philadelphia resident who shared the story of her personal journey with chronic hepatitis B infection.

Philadelphia is closely linked to the discovery of and efforts to combat the hepatitis B virus. The late Dr. Baruch Blumberg was at Fox Chase Cancer Center in 1967 when he identified the hepatitis B virus, for which he won the Nobel Prize in Medicine. He also co-invented the vaccine for hepatitis B, which is manufactured by two companies, Merck and GlaxoSmithKline, both headquartered in the Philadelphia region. The first animal that was discovered to be most useful in studying hepatitis B was a groundhog living at the Philadelphia Zoo, and the only national nonprofit organization dedicated to finding a cure for hepatitis B, the Hepatitis B Foundation, was established just outside Philadelphia.

About the Hepatitis B Foundation: The Hepatitis B Foundation is the nation’s leading nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. To learn more, go to hepb.org, read our blog at wp.hepb.org, follow us on Twitter @HepBFoundation, find us on Facebook at facebook.com/hepbfoundation or call 215-489-4900.

Read the full story at http://www.prweb.com/releases/2016/06/prweb13453032.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. NACDS Foundation Assisting National Hepatitis Testing Push
2. Hepatology, Medicine and Policy Journal Publishes Findings from Hepatitis B Foundation ‘Gateway to Care’ Campaign in China
3. Special Issue of AJMC Examines Policy Questions Surrounding Hepatitis C Treatment
4. Hepatitis B Foundation Marks 25th Anniversary at 2016 Crystal Ball Gala
5. BioPlus Specialty Pharmacy to Provide New FDA Approved Hepatitis C Combination Zepatier™ (grazoprevir/elbasvir)
6. Hepatitis B Foundation’s ‘Nobel Challenge’ Raises $3 Million to Support Research for a Cure
7. Hepatitis B Foundation Leaders Help Shape National Plan to Eliminate Hepatitis B and C
8. Journal of the National Cancer Institute Publishes Summary of Hepatitis B Foundation’s Liver Cancer Workshop
9. Mercy Medical Center's Dr. Paul J. Thuluvath Authors New Book, "Hepatitis C: A Complete Guide for Patients and Families"
10. Grammy-Winning Artist Natalie Cole Joins Mediaplanet to Amplify Awareness of Hepatitis C, the “Silent Killer”
11. CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board ... Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will ... Dr. Puffer’s retirement at the end of 2018. Upon assuming the role of President ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor ... prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. The ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at ... towards children of all ages; it is a non-competitive, non-timed event, which is all ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
Breaking Medicine Technology: